Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
Glioblastoma multiforme (GBM) is rare and fatal glioma with limited treatment options.Treatments provide minimal improvement in prognosis and only 6.8% of GBM patients have a life expectancy greater than five years.Surgical resection of this malignant glioma is difficult due to its highly invasive nature and follow-up radiotherapy with concomitant